What Is Inflammaging? A Catchy Name for a Serious Issue
Key Takeaways
- Inflammaging is the slow, low-grade inflammation that builds quietly with age. It runs in the background, and most people don't feel it directly.
- Researchers now link inflammaging to most major age-related conditions. The list includes heart disease, type 2 diabetes, frailty, brain decline, and many forms of cancer.
- What is inflammaging doing day to day? It often shows up as slower recovery, joint stiffness that lingers, lower steady energy, and small daily wear that adds up over the years.
- There is no single test for inflammaging, and no single fix. The science points to four cellular problems to work on together: oxidative stress, weak mitochondria, poor cell signaling, and slow cleanup.
- Diet and lifestyle do most of the work. A daily routine of researched ingredients can support the underlying biology once that foundation is set.
What Is Inflammaging in Plain Language?
You used to bounce back. A long hike on Saturday meant a slightly stiff Sunday morning, then Monday felt fine. The garden didn't take three days to recover from. Lately, recovery runs longer. Stiffness lingers. There is a sense of running just slightly hot all the time, even when nothing is obviously wrong.
That feeling has a name. Researchers call it inflammaging, the chronic, low-grade, sterile (meaning non-infectious) inflammation that develops with age. The term was coined in 2000 by the immunologist Claudio Franceschi. Over the past two decades it has become a central concept in the science of healthy aging at the cellular level.
So, when you ask, “what is inflammaging,” you are asking about something the field now considers a major upstream driver of how our bodies change in midlife and beyond.
Inflammaging behaves differently from other kinds of inflammation. A sprained ankle, a sore throat, a flu, those are acute inflammation, the body's short-term response to injury or infection. Autoimmune conditions like rheumatoid arthritis or lupus are something different again, an immune system that has turned against the body's own tissues. Inflammaging is the quiet, sustained, low-grade signal that something at the cellular level keeps asking for help and getting an incomplete answer.
The catchy name carries a serious idea. The longer that low-grade signal runs, the more cumulative wear it does to the tissues it passes through. That wear is much of what shows up as the slow shift Active Agers know all too well.
 |
The science: Inflammaging is the chronic, low-grade, sterile inflammation that develops with age. The current scientific understanding describes it as a systemic (body-wide) outcome of multiple cellular failures happening in parallel.
The evidence: A 2014 review in the Journals of Gerontology by Franceschi and Campisi summarized the evidence linking chronic, low-grade inflammation to age-associated diseases and proposed the framework that has since shaped most of the field. |
What Does Inflammaging Mean for Healthy Aging?
What does inflammaging mean for the body over the long run? In a word, plenty. The field's growing concern about inflammaging extends well beyond discomfort. In practice, what does inflammaging mean? This background state has been linked, in human studies, to most of the conditions that limit later life. Cardiovascular disease. Type 2 diabetes. Sarcopenia, the gradual loss of muscle. Frailty. Neurodegenerative diseases including Alzheimer's and Parkinson's. Several forms of cancer. These connections rest on biology.
A 2019 review in Nature Medicine put the case plainly. It synthesized population data and mechanistic studies and argued that chronic inflammation contributes meaningfully to the development of cardiovascular disease, cancer, diabetes, neurodegeneration, and other age-related conditions across the human life span. The relationship is seen consistently across large groups at the population level and with a known biological pathway at the cellular level. The argument is careful. Researchers describe inflammaging as a meaningful upstream contributor to age-related disease, one of several drivers identified in geroscience (the study of how aging drives disease).
For an Active Ager, what does inflammaging mean for daily life? It means that the small wear-and-tear signals you have probably been chalking up to "just getting older" may share a common upstream origin. The same biology that makes recovery slower can also be making blood vessels stiffer, joints less forgiving, and tissues less resilient. Addressing the upstream signal becomes a meaningfully different way of thinking about healthy aging.
That reframe is what makes the science worth your attention. There are levers. Some of them are in your kitchen. Some of them are in your daily routine. The rest of this post walks through what the science suggests and where, honestly, the evidence is strongest.
What Are the Symptoms of Inflammaging?
Inflammaging usually does not arrive with symptoms you can point to. It is more a slow shift in baseline. The Sunday hike that used to take a Sunday evening to recover from now bleeds into Monday. The garden bed takes two days to weed where it used to take one. The morning stiffness that used to be five minutes now runs longer. Energy is steady but lower than it used to be. Cuts heal more slowly than they once did. Together, those small shifts are how inflammaging symptoms typically present.
Inflammaging symptoms accumulate slowly and persistently. They show up as a longer recovery curve, a quieter floor of energy, and a body that takes more days to come back to itself. Reading inflammaging symptoms accurately means watching for the pattern over months and years.
There is no single clinical test for inflammaging. The most studied biomarkers (measurable signs in the blood) are high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α). Elevated levels of these markers track with worse health outcomes across older adults in population studies. They overlap with many other conditions, though, so they are interpreted in context.
Common inflammaging symptoms in midlife and beyond include:
- Slower recovery from physical exertion (the long walk, the round of golf, the morning of yard work).
- Joint stiffness that lingers a day longer than it used to.
- Steady fatigue that does not track with how you slept.
- Slower wound healing.
- Gradual loss of muscle mass and bone density over years.
- A sense of being more easily knocked off-rhythm by stress, travel, or illness.
If your symptom pattern is acute, severe, or autoimmune-shaped, that is a different conversation with your clinician. Inflammaging is the steady backdrop. The point of naming inflammaging symptoms is to recognize the pattern and act upstream of it. Recognizing what inflammaging looks like in your own daily life is the first step toward addressing it.
What Is Inflammaging Doing at the Cellular Level?
What is inflammaging actually doing inside cells? The current scientific understanding points to four cellular failures that feed into the same inflammatory output. Naming them sets up the response that follows.
Mitochondrial Dysfunction
Mitochondria are the small organelles inside almost every cell that produce ATP, the body's energy currency. As we age, mitochondria leak more reactive oxygen species (ROS), the chemical "exhaust" of energy production. They also release fragments of mitochondrial DNA into the cytoplasm (the fluid inside the cell). The cell reads those fragments as if they were bacterial DNA and activates NF-κB, the master inflammatory switch.
Cellular Senescence and SASP
Senescent cells are old cells that stop dividing yet remain alive. They were supposed to retire. Instead, they secrete a cocktail of inflammatory cytokines (cell-signaling proteins) called the senescence-associated secretory phenotype, or SASP, which includes IL-6, IL-1β, and TNF-α. A 2015 Nature Medicine review describes how senescent cells accumulate with age and act as steady inflammatory transmitters.
Decline of Nrf2 Signaling
Nrf2 is the master switch that turns on the body's own antioxidant defenses, including glutathione, the most important antioxidant the body makes on its own. Nrf2 responsiveness drops with age. The cell becomes less able to make its own defense compounds, oxidative damage rises, and that damage feeds NF-κB inflammation. Research on Nrf2 activators explains why activating Nrf2 is one of the few intervention points known to restore the body's own antioxidant capacity.
Loss of Autophagy
Autophagy is the cell's recycling system for damaged proteins and organelles. With age, that recycling slows. Damaged components accumulate. The cell perceives the accumulation as stress, and the stress signals feed back into low-grade inflammation.
Table 1. The Four Cellular Drivers of Inflammaging
| Driver | What's Happening Biologically | Pillar It Maps To |
|---|---|---|
| Mitochondrial dysfunction | Aging mitochondria leak more ROS and release mitochondrial DNA fragments, triggering NF-κB | Power Plant |
| Cellular senescence and SASP | Senescent cells secrete inflammatory cytokines (IL-6, IL-1β, TNF-α) | Cleanup |
| Decline of Nrf2 signaling | Reduced internal antioxidant production and lower glutathione | Signal |
| Loss of autophagy | Damaged proteins and organelles accumulate, raising stress signals | Cleanup |
In Plain Terms: Aging cells stop running as cleanly as they used to. The mitochondria leak more, old cells keep sending alarm signals, and the body's own defenses get weaker. All four problems push the same inflammation switch. Over years, that low background hum is what we call inflammaging.
Inflammaging is the systemic outcome of four cellular failures happening at once. The intelligent response addresses all four.
How Inflammaging and Cancer Connect
The link between inflammaging and cancer is one of the better-established connections in geroscience. When researchers ask what inflammaging contributes to cancer biology, the short answer is: more than the field used to think. Chronic, low-grade inflammation is now considered one of the enabling characteristics of cancer biology, alongside the more familiar drivers like genetic mutation and tissue damage. The Hanahan and Weinberg framework "Hallmarks of Cancer," updated in 2011, includes tumor-promoting inflammation as one of the recognized hallmarks.
The biological logic is straightforward. Chronic inflammatory signaling promotes the kind of tissue remodeling (changes in the structure of nearby tissues) that supports tumor growth. It erodes immune surveillance, the body's ability to identify and clear abnormal cells. The sustained oxidative stress that accompanies inflammation contributes to DNA damage that can drive mutation. In the 2019 Nature Medicine review, cancer is named alongside cardiovascular disease, type 2 diabetes, and neurodegeneration. Its development, like theirs, is meaningfully shaped by chronic inflammation across the human lifespan.
The connection between inflammaging and cancer is biological background. The science here describes upstream signaling. Supplements, dietary patterns, and daily routines are tools for supporting a healthier baseline, and the literature stops well short of presenting them as cancer interventions. The relationship between inflammaging and cancer is part of why the broader response to inflammaging matters at all.
For an Active Ager, the practical takeaway is simple. The same things that support healthy cellular signaling also tend to support a healthier inflammatory baseline. The same upstream attention that may help with energy, recovery, and resilience is acting on deeper biology. That biology connects to a much wider range of long-term outcomes than just how Sundays feel after a long Saturday hike.
The science here is associational and mechanistic. It describes relationships and pathways at the population level, leaving room for individual variation. The conversation about inflammaging and cancer is a conversation about long-term risk patterns, with no guarantee at the individual level. Both pieces of that nuance matter when reading the inflammaging and cancer literature. The next question, then, is how inflammaging is best addressed, in practical terms, when the goal is healthy aging over decades.
What's the Treatment for Inflammaging?
If you search online for what is inflammaging and how to address it, you find a mix of clinical research, supplement marketing, and lifestyle advice. Here is the honest version. There is no single pharmaceutical treatment for inflammaging in the way there is, say, a treatment for high cholesterol. Searching for the most effective treatment for inflammaging tends to surface a mix of biotech research years away from clinical use and lifestyle interventions that already have human-trial data behind them. Inflammaging behaves as the shared output of those four cellular failures, and the most evidence-based response is sustained attention to the upstream cellular drivers, applied consistently over time.
What the science does support, repeatedly and across many large studies, is that lifestyle and diet do most of the work. The Mediterranean diet, rich in olive oil, nuts, vegetables, fruits, whole grains, fish, and legumes, has the strongest evidence base for reducing inflammatory biomarkers in human studies.
|
|
The science: A Mediterranean-pattern diet rich in olive oil, nuts, vegetables, fruits, and whole grains is associated with lower markers of chronic inflammation and better cardiovascular outcomes in long-term human studies. The evidence: The PREDIMED trial, published in the New England Journal of Medicine found that participants assigned to a Mediterranean diet supplemented with extra-virgin olive oil or nuts had measurable reductions in inflammatory biomarkers and a lower rate of major cardiovascular events compared with a control diet. The 2013 publication was retracted in 2018 and replaced with a corrected version. The corrected publication reported similar effect sizes after addressing randomization errors that affected about 21% of participants. |
Beyond diet, the research supports several daily foundations:
- A Mediterranean-pattern diet, eaten consistently over years rather than weeks.
- Regular movement, including both moderate aerobic activity and strength training. The dose-response is modest at first and meaningful over time.
- Sleep quality. Chronic short or fragmented sleep raises inflammatory biomarkers in human studies.
- Stress regulation. Practices that lower the automatic stress response, including breath work, time in nature, and supportive social connection, reduce chronic inflammatory signaling.
- A focused daily routine of clinically researched ingredients can support the cellular pathways involved in inflammaging when the foundation is already in place.
That fifth point is where supplements live in the conversation about a treatment for inflammaging. They work as part of the foundation, complementing diet and lifestyle. With the foundation in place, certain ingredients have ingredient-level research for supporting the cellular pathways that the inflammaging research identifies as upstream. The honest map of treatment for inflammaging in 2026 still leads back to lifestyle, with cellular support as a complement.
Studies cited above describe dietary patterns and individual ingredients, not the ResilienZ-12™ formula. Ingredient and dose selection in ResilienZ-12™ is informed by this research, not equivalent to it.
A Smarter Framework for Addressing Inflammaging
The four cellular drivers of inflammaging do not have a single antidote. That is why a multi-pathway, complementary approach is more biologically defensible than any single anti-inflammatory ingredient. Asking what inflammaging actually requires at the cellular level helps explain why a multi-front response makes sense. ResilienZ-12™ is built around a Four-Pillar Framework that maps onto those four cellular drivers, with each pillar naming a distinct cellular role and the specific ingredients that support it.
Signal: Activating the Body's Own Defense Pathways
The Signal pillar focuses on activating the body's own internal defense pathways, specifically Nrf2 and the sirtuins (a family of proteins involved in cellular repair). Signal is the master-switch pillar. It works by telling the cell to protect itself, drawing on the body's own defense systems. Activated BroccoRaphanin Plus® with myrosinase (the enzyme that lets the body form sulforaphane) delivers sulforaphane, the compound that most consistently activates Nrf2 in human research. Trans-resveratrol activates SIRT1, the sirtuin most associated with autophagy and dampening NF-κB-driven inflammation.
Shield: Direct Antioxidant Defense
Shield is the pillar most readers think of when they hear "antioxidant." It is the direct neutralization of free radicals across both water-soluble and fat-soluble cellular environments. Shield in ResilienZ-12™ runs across seven complementary ingredients:
- Vitamin C, working in the water-soluble compartment.
- Mixed tocotrienols and tocopherol complex, working in lipid membranes.
- Lycopene, fat-soluble.
- Astaxanthin, fat-soluble with broad cellular reach.
- Decaffeinated green tea extract (with the polyphenol EGCG), working across compartments.
- Quercetin, with broad inflammatory-pathway support.
- Meriva® Curcumin Phytosome® from Indena®, the brand's primary curcumin delivery in a phytosomal form chosen for better curcumin absorption, with broad inflammatory-pathway support.
The literature on quercetin's role in inflammation and immunity and on bioavailable curcumin and chronic inflammation is well established in independent peer-reviewed reviews.
Power Plant: Mitochondrial Support
Power Plant is the pillar that addresses mitochondrial decline directly. The goal is to support mitochondrial function so the "exhaust" of energy production stays cleaner. CoQ10 sits at the center of the mitochondrial electron transport chain (the cell’s main energy-production line), where its role in cellular energy production and healthy aging is well documented in the cellular-energy literature. Alpha-lipoic acid supports mitochondrial energy production and also recycles other antioxidants, giving it a secondary role in Shield.
Cleanup: Cellular Renewal Over Time
Cleanup is the long-horizon pillar. It supports the biological processes of autophagy (cellular recycling) and broader cellular renewal that keep cellular order from drifting over time. Trans-resveratrol's autophagy support via SIRT1/AMPK is its secondary role. Quercetin has shown research-stage senolytic activity in early human work(selectively clearing worn-out senescent cells) when given in combination with a prescription compound. That literature is research-stage. It does not constitute a senolytic claim about the finished ResilienZ-12™ formula. Meriva® Curcumin Phytosome® supports autophagy as a secondary role to its primary Shield function.
In Plain Terms: Inflammaging happens because four things go wrong inside the cell at once. The body needs help on all four fronts. The Four-Pillar Framework names the four jobs: Signal, Shield, Power Plant, and Cleanup. ResilienZ-12™ puts research-backed ingredients into each one.
Studies cited above describe individual ingredients and cellular mechanisms, not the ResilienZ-12™ finished formula. Ingredient and dose selection in ResilienZ-12™ is informed by this research, not equivalent to it.
Where ResilienZ-12™ Fits Into the Picture
ResilienZ Health started from a founding observation: many health-conscious adults end up managing a cabinet of 8 to 12 bottles, and consistency tends to slip as that routine grows. ResilienZ-12™ is the simplified longevity stack designed around the Four-Pillar Framework. Twelve complementary ingredients at clinically credible, research-aligned doses, in three vegan capsules, taken daily. ResilienZ-12™ is positioned as daily support for healthier aging, designed for long-term consistent use. That is the same time horizon over which the underlying cellular biology of healthy aging operates.
Picture an Active Ager who already eats well, moves regularly, sleeps reasonably, and pays attention to stress. For them, ResilienZ-12™ is a focused daily routine designed to support the cellular pathways the inflammaging research identifies as upstream. The foundation does most of the work. ResilienZ-12™ supports the cellular pathways that the foundation depends on.
What does inflammaging mean for an Active Ager's daily routine? It comes down to consistency: showing up for diet, movement, sleep, and stress over years, with cellular support that complements the foundation. That is what simplified looks like in practice. One bottle. Three capsules. Twelve ingredients across four pillars, every day.
The goal is the steady, repeatable practice that the underlying biology rewards over the long run. If the case for simplifying a complicated supplement routine resonates, ResilienZ-12™ is what that case looks like in three capsules.
Frequently Asked Questions
What Is Inflammaging in Simple Terms?
What is inflammaging? Inflammaging is the chronic, low-grade, sterile inflammation that develops with age. It runs in the background, distinct from acute inflammation like a flu or sprain and from autoimmune conditions like rheumatoid arthritis. Researchers now link it to most major age-related conditions, which is why understanding it matters for healthy aging.
What Does Inflammaging Mean for Someone Over 60?
What does inflammaging mean in practice for an Active Ager? Slower recovery from physical exertion. Lingering joint stiffness. Lower steady energy. A gradual loss of resilience. The science suggests addressing four cellular drivers in parallel through diet, movement, sleep, stress regulation, and a focused daily routine of clinically researched ingredients that support the underlying cellular biology.
What Are the Symptoms of Inflammaging?
Inflammaging symptoms are usually indirect: slower recovery, persistent low-grade joint stiffness, fatigue that does not track with sleep, slower wound healing, and gradual loss of muscle mass. There is no single clinical test for inflammaging symptoms; the most studied biomarkers (hsCRP, IL-6, TNF-α) overlap with many other conditions and are interpreted in context.
Is There a Connection Between Inflammaging and Cancer?
Yes. Inflammaging and cancer are connected because chronic, low-grade inflammation is now considered one of the enabling characteristics of cancer biology. The 2019 Nature Medicine review placed inflammation among the meaningful contributors to cancer initiation and progression, alongside other age-related diseases. The connection is biological background at the population level.
What's the Most Evidence-Based Treatment for Inflammaging?
The most evidence-based response to inflammaging is foundational. A Mediterranean-pattern diet, regular movement, sleep, and stress regulation each reduce inflammatory biomarkers in human studies. There is no single pharmaceutical treatment for inflammaging in the conventional sense. The science points to addressing upstream cellular drivers consistently over time, supported by clinically researched ingredients where appropriate.
Where Does a Daily Supplement Fit In?
A focused daily supplement routine fits as a complement to a strong dietary and lifestyle foundation. ResilienZ-12™ is built around the Four-Pillar Framework: Signal, Shield, Power Plant, and Cleanup. Each pillar supports one of the cellular pathways that the inflammaging research identifies as upstream of age-related decline. The product is daily support for healthier aging, taken as part of a consistent routine.
Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
References
Bonkowski, M. S., & Sinclair, D. A. (2016). Slowing ageing by design: The rise of NAD+ and sirtuin-activating compounds. Nature Reviews Molecular Cell Biology, 17(11), 679–690.
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015). Cellular senescence in aging and age-related disease: From mechanisms to therapy. Nature Medicine, 21(12), 1424–1435.
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M. I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., Lamuela-Raventos, R. M., Serra-Majem, L., Pintó, X., Basora, J., Muñoz, M. A., Sorlí, J. V., Martínez, J. A., & Martínez-González, M. A. (2018). Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. New England Journal of Medicine, 378(25), e34.
Franceschi, C., & Campisi, J. (2014). Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 69(Suppl 1), S4–S9.
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., Miller, A. H., Mantovani, A., Weyand, C. M., Barzilai, N., Goronzy, J. J., Rando, T. A., Effros, R. B., Lucia, A., Kleinstreuer, N., & Slavich, G. M. (2019). Chronic inflammation in the etiology of disease across the life span. Nature Medicine, 25(12), 1822–1832.
Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144(5), 646–674.
Hernández-Camacho, J. D., Bernier, M., López-Lluch, G., & Navas, P. (2018). Coenzyme Q10 supplementation in aging and disease. Frontiers in Physiology, 9, 44.
Hewlings, S. J., & Kalman, D. S. (2017). Curcumin: A review of its effects on human health. Foods, 6(10), 92.
Houghton, C. A., Fassett, R. G., & Coombes, J. S. (2016). Sulforaphane and other nutrigenomic Nrf2 activators: Can the clinician's expectation be matched by the reality? Oxidative Medicine and Cellular Longevity, 2016, 7857186.
Justice, J. N., Nambiar, A. M., Tchkonia, T., LeBrasseur, N. K., Pascual, R., Hashmi, S. K., Prata, L., Masternak, M. M., Kritchevsky, S. B., Musi, N., & Kirkland, J. L. (2019). Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study. EBioMedicine, 40, 554–563.
Li, Y., Yao, J., Han, C., Yang, J., Chaudhry, M. T., Wang, S., Liu, H., & Yin, Y. (2016). Quercetin, inflammation and immunity. Nutrients, 8(3), 167.
Singh, T., & Newman, A. B. (2011). Inflammatory markers in population studies of aging. Ageing Research Reviews, 10(3), 319–329.